Demurrageiq

DemurrageiqDemurrageiq
D

Demurrageiq

AI-powered platform to eliminate preventable demurrage and detention charges.

Active

About

DemurrageIQ is an AI-powered freight forwarder and demurrage avoidance platform that helps businesses track containers, catch avoidable fees, and recover incorrect carrier invoices. It offers automated free-time tracking, AI document analysis to identify mismatches, and a dispute engine to streamline the recovery of overcharges for ocean freight. The platform serves businesses looking to eliminate costly demurrage and detention charges.
Frequently asked

What does Demurrageiq do?

DemurrageIQ is an AI-powered freight forwarder and demurrage avoidance platform that helps businesses track containers, catch avoidable fees, and recover incorrect carrier invoices. It offers automated free-time tracking, AI document analysis to identify mismatches, and a dispute engine to streamline the recovery of overcharges for ocean freight. The platform serves businesses looking to eliminate costly demurrage and detention charges.

What industry does Demurrageiq operate in?

Demurrageiq operates in LogisticsTech, Supply Chain, FreightTech, Maritime Logistics, AI Tool, Workflow Automation.

New entrants in LogisticsTech
Last 90 days
58
New entrants
19.3
Per month
4.5
Per week

An entrant is a company tagged LogisticsTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 8 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Scores
Measured, not editorial
Agent Readiness
38/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.